Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | PKM | P14618 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 9/20 | 0.41 |
| ▸ | METAP1 | P53582 | 8/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | CBFB | Q13951 | 9/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | STAT1 | P42224 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL11325081 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL31229487 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL28757530 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL6071532 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL31678981 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL28446738 | 0.99 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| Bromide SCHEMBL11343585 | 0.97 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| Iodide SCHEMBL11338884 | 0.97 | NPC1 (0.40) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| SCHEMBL28268017 | 0.89 | AURKA (0.45) | NPC1PKMRAB9ASMN1; SMN2LMNA | |
| Dipyridyl SCHEMBL28212071 | 0.86 | METAP1 (0.50) | NPC1PKMRAB9ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039608-B | Photosensitive molecular junction with photoelectric response rectification function and preparation method and application thereof | 广东工业大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119039608-A | Photosensitive molecular junction with photoelectric response rectification function and preparation method and application thereof | 广东工业大学 | 2024-11-29 | — | — | CN | claimed |
| US-20240148749-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | PASTEUR INSTITUT (FR) | 2024-05-09 | — | — | US | claimed |
| EP-4308107-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | INSTITUT PASTEUR (FR) | 2024-01-24 | — | — | EP | claimed |
| CN-116902960-A | N and S co-doped carbon material, preparation method and application thereof in zinc-air battery | 大连民族大学 | 2023-10-20 | — | — | CN | claimed |
| CN-115160582-B | Crystalline trimetallic pyridine porphyrin porous complex and preparation method and application thereof | 闽都创新实验室 | 2023-09-05 | — | — | CN | claimed |
| US-20230149451-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OXIDIZABLE BIPHENOL AND MANGANESE PORPHYRIN, AND METHOD OF USING THE SAME | VILLANOVA UNIVERSITY (US) | 2023-05-18 | — | — | US | claimed |
| CN-115945220-A | Ir metal-based biocatalyst and preparation method and application thereof | 四川大学 | 2023-04-11 | — | — | CN | claimed |
| CN-115160582-A | Crystalline trimetal pyridine porphyrin porous complex and preparation method and application thereof | 闽都创新实验室 | 2022-10-11 | — | — | CN | claimed |
| CN-115000372-A | Preparation method and application of metalloporphyrin/graphene composite structure | 北京科技大学 | 2022-09-02 | — | — | CN | claimed |
| CN-107805254-A | A kind of porphyrin small molecule perovskite cathode cushioning layer material and preparation method and application | 华南理工大学 | 2018-03-16 | — | — | CN | claimed |
| CN-104650104-B | The preparation method of zinc ion-porphyrin nano complex | 深圳市正科技有限公司 | 2017-01-04 | — | — | CN | claimed |
| CN-105688995-A | Method for preparing metalloporphyrin-graphene nano composite material under condition of room temperature | 湖南科技大学 | 2016-06-22 | — | — | CN | claimed |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | FUJIFILM CORPORATION (JP) | 2015-12-31 | — | — | US | claimed |
| CN-104862373-A | High-throughput screening method of photodynamic antibacterial photosensitizer | UNIV HEBEI TECHNOLOGY | 2015-08-26 | — | — | CN | claimed |
| CN-104650104-A | Preparation method of zinc ion-porphyrin nanometer complex | SHENZHEN E ZHENG TECH CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-104253225-A | Preparation method of large-area ordered organic p-n junction nanowire array | CHINESE ACAD INST CHEMISTRY | 2014-12-31 | — | — | CN | claimed |
| US-8530614-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2013-09-10 | — | — | US | claimed |
| US-8324342-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2012-12-04 | — | — | US | claimed |
| CN-102408452-A | Tetrapyridylporphyrin bridged cross-shaped tetranuclear platinum complex and preparation method and antitumor activity thereof | UNIV SUN YAT SEN | 2012-04-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148749-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | PEBP1, TPX2, MPEG1 | NPC1 3417/4885PKM 1574/4885RAB9A 3708/4885 |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | CA3, NIT2, NOX3 | NPC1 3322/4885PKM 3125/4885RAB9A 1185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.